Molecular Imaging of the Tumor Microenvironment
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Radiopharmaceutical Sciences".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 1335
Special Issue Editor
Interests: biomolecular imaging; biology; molecular diagnostics; tumor metabolism; tumor immune microenvironment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
With the progress in research, we all acknowledge that treating cancer involves focusing on cancer cells and understanding their interactions with the surrounding cells and extracellular matrix, which compose the tumor microenvironments (TME). Immunotherapies have recently shown promising results in various types of cancers, and the concept of the tumor microenvironment has expanded to include immune-related components such as immune cells and cytokines. Consequently, a new field of research called the tumor immune microenvironment (TIME) has been proposed and actively explored.
Traditionally, many animals have to be used to study specific events occurring in the TME/TIME because they need to be sacrificed to conduct different experiments. However, with the emergence and utilization of molecular imaging in biomedical research, disease progression and interactions between multiple cell types or overall tumor microenvironmental changes can be tracked employing various imaging instruments noninvasively at multiple time points using the same cohort of animals.
We welcome original research articles, editorials and review articles.
Dr. Hui-Yen Chuang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular imaging
- radiopharmaceuticals
- tumor microenvironment
- immune microenvironment
- angiogenesis
- pH sensors
- theranostics
- nanoparticles
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
